Search results
Here's Why Novartis (NVS) is a Strong Value Stock
Zacks via Yahoo News· 2 weeks agoTaking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. While you may have an investing...
Data breach at medical giant Cencora exposes info from multiple drug companies
TechRadar via Yahoo News· 1 month agoHealthcare. Almost a dozen pharmaceutical companies, including several major players, have lost...
Is Trending Stock Novartis AG (NVS) a Buy Now?
Zacks via Yahoo News· 4 months agoNovartis (NVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the...
Novartis (NVS) Raises Mid-Term Sales Outlook; Outlines Strategy
Zacks via Yahoo News· 7 months agoSwiss pharma giant Novartis NVS raised its sales and operating income goals for the mid-term, post...
Novartis (NVS) Stock Moves -0.2%: What You Should Know
Zacks via Yahoo News· 10 months agoNovartis (NVS) closed at $97.89 in the latest trading session, marking a -0.2% move from the prior...
Novartis (NVS) Stock Dips While Market Gains: Key Facts
Zacks via Yahoo News· 4 months agoNovartis (NVS) closed the latest trading day at $99.77, indicating a -1.58% change from the previous...
Novartis (NVS) Stock Slides as Market Rises: Facts to Know Before You Trade
Zacks via Yahoo News· 6 months agoIn the latest market close, Novartis (NVS) reached $108.03, with a -0.21% movement compared to the...
Novartis (NVS) Beats Stock Market Upswing: What Investors Need to Know
Zacks via Yahoo News· 6 months agoIn the latest trading session, Novartis (NVS) closed at $106.31, marking a +0.7% move from the...
Novartis (NVS) Increases Yet Falls Behind Market: What Investors Need to Know
Zacks via Yahoo News· 4 months agoThe latest trading session saw Novartis (NVS) ending at $96.32, denoting a +0.42% adjustment from...
Novartis (NVS) Announces Positive Long-Term Data on Leqvio
Zacks via Yahoo News· 10 months agoNovartis NVS announced new long-term data on the cholesterol-lowering drug Leqvio at the European...